XLVE - Mulvihill ETFs: U.S. Health Care Enhanced Yield ETF
Mulvihill's XLVE ETF offers exposure to large-cap US healthcare stocks with 25% leverage used for purchasing additional shares to write options, generating income from option premiums while maintaining close to "full" exposure to underlying portfolio stocks.
Gain Access to High-Yield Healthcare Investing with Mulvihill's XLVE ETF
Mulvihill's XLVE ETF offers exposure to large-cap US healthcare stocks with 25% leverage used for purchasing additional shares to write options, generating income from option premiums while maintaining close to "full" exposure to underlying portfolio stocks. This combination provides yield enhancement benefits of option writing strategies without sacrificing upside potential in rising markets. Additionally, the ETF hedges US dollar exposure back to Canadian dollars.XLVE is a new ETF by Mulvihill that offers exposure to leading large cap US healthcare stocks. It has a current yield of 7% and offers monthly distributions, which is more than four times the S&P 500 Health Care Index.
For more information on Mulvihill ETFs (TSX: XLVE) view their video HERE.
Published by BTV - The Agency
Discover Investment Opportunities with BTV. Delivering engaging content to Investors for 25+ years. Visit b-tv.com.
.jpg)
You might also like
.jpeg)
Picard Medical / SynCardia Tackling One of the Largest Unmet Needs in Cardiovascular Medicine
Advanced heart failure continues to rise globally, while the supply of donor hearts remains limited. This structural imbalance creates a significant and expanding market opportunity, with thousands of patients each year lacking viable treatment options and placing growing economic pressure on healthcare systems.
